Press Release: EU-funded scientists decode proteins with potential for new medicines

An EU-funded research team, working with scientists at Stanford University in the US and the European synchrotron radiation facility in Grenoble, is the first to determine the structure of a specific membrane protein, known as "recombinant G protein-coupled receptor". Membrane proteins are potentially very important targets for future medicines, because of their involvement in the development of many diseases within the body. In addition to this exciting discovery, the European Commission is announcing around €22m of funding for two new projects looking into membrane proteins, one of which involves two previous Nobel prize-winners.